自己免疫疾患診断の世界市場：洞察、競合情勢、市場予測：2028年

世界の自己免疫疾患診断の市場規模は、2023年～2028年の予測期間中に5.53%のCAGRで拡大し、2028年には64億1,000万米ドルに達すると予測されています。自己免疫疾患診断の需要は、主に関節リウマチ、i型糖尿病、アジソン病などの自己免疫疾患の症例数の増加によって後押しされています。さらに、病気の早期診断に関する人々の意識の高まりや、ヘルスケア領域における技術進歩の高まりも、2023年～2028年の予測期間における自己免疫疾患診断薬市場の成長に寄与しています。

国際多発性硬化症連盟が2020年に発表したデータによると、多発性硬化症に罹患する人の数は、世界全体で2013年の230万人から2020年には28億人に増加しています。さらに、世界保健機関（WHO）が2023年に提供した統計によると、2019年には世界中で約1,800万人が関節リウマチに苦しんでいます。同資料によると、2019年に関節リウマチに罹患した人の約70％は女性で、55％は55歳以上でした。このように、自己免疫疾患の有病率の上昇は、自己免疫疾患の診断の必要性を生み出し、その結果、自己免疫疾患診断市場のプラス成長をもたらします。

自己免疫疾患診断市場のもう一つの促進要因は、疾患の早期発見に関する社会的認知の高まりです。例えば、自己免疫協会は毎年3月に自己免疫疾患啓発月間を認定しています。この啓発キャンペーンの主な目的は、自己免疫疾患に関する一般市民の知識と理解を高めることです。このように、病気に対する認識が高まることで、病気の早期診断が求められるようになり、これが自己免疫疾患診断薬市場を牽引する上で重要な役割を果たしています。

しかし、自己免疫疾患の診断にかかるコストが高いこと、診断までの時間が長いこと、多くの検査が必要であることなどが、自己免疫疾患診断市場の成長を制限する可能性のある主要な抑制要因となっています。

当レポートでは、世界の自己免疫疾患診断市場について調査し、市場の概要とともに、製品別、疾患タイプ別、検査別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 自己免疫疾患診断市場レポートのイントロダクション

第2章 自己免疫疾患診断市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 自己免疫疾患診断市場の主要な要因分析

• 自己免疫疾患診断市場の促進要因
• 自己免疫疾患診断市場の抑制要因と課題
• 自己免疫疾患診断市場の機会

第5章 自己免疫疾患診断市場におけるポーターのファイブフォース分析

第6章 自己免疫疾患診断市場の概要

• 製品別
• 疾患タイプ別
• 検査別
• エンドユーザー別
• 地域別

第7章 自己免疫診断市場における企業と製品の概要

• Bio-Rad Laboratories
• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Grifols, S.A
• Beckman Coulter, Inc.
• Siemens Healthineers
• Exagen Inc.
• Medical & Biological Laboratories Co. Ltd.
• RSR Limited
• DiaSorin S.p.A
• Werfen
• EUROIMMUN Medizinische Labordiagnostika AG
• Laboratory Corporation of America Holdings
• Abcam plc
• Quest Diagnostics
• Hemagen Diagnostics, Inc
• AESKU Diagnostics GmbH & Co. KG
• Trinity Biotech
• Biomerieux SA

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Autoimmune Disease Diagnostics Market in Global (2020-2028)
• Table 3: Autoimmune Disease Diagnostics Market in Global by Product (2020-2028)
• Table 4: Autoimmune Disease Diagnostics Market in Global by Diseases Type (2020-2028)
• Table 5: Autoimmune Disease Diagnostics Market in Global by Test (2020-2028)
• Table 6: Autoimmune Disease Diagnostics Market in Global by End-users (2020-2028)
• Table 7: Autoimmune Disease Diagnostics Market in Global by Geography (2020-2028)
• Table 8: Autoimmune Disease Diagnostics Market in North America (2020-2028)
• Table 9: Autoimmune Disease Diagnostics Market in North America by Country (2020-2028)
• Table 10: Autoimmune Disease Diagnostics Market in the US (2020-2028)
• Table 11: Autoimmune Disease Diagnostics Market in Canada (2020-2028)
• Table 12: Autoimmune Disease Diagnostics Market in Mexico (2020-2028)
• Table 13: Autoimmune Disease Diagnostics Market in Europe (2020-2028)
• Table 14: Autoimmune Disease Diagnostics Market in Europe by Country (2020-2028)
• Table 15: Autoimmune Disease Diagnostics Market in France (2020-2028)
• Table 16: Autoimmune Disease Diagnostics Market in Germany (2020-2028)
• Table 17: Autoimmune Disease Diagnostics Market in the United Kingdom (2020-2028)
• Table 18: Autoimmune Disease Diagnostics Market in Italy (2020-2028)
• Table 19: Autoimmune Disease Diagnostics Market in Spain (2020-2028)
• Table 20: Autoimmune Disease Diagnostics Market in the Rest of Europe (2020-2028)
• Table 21: Autoimmune Disease Diagnostics Market in Asia-Pacific (2020-2028)
• Table 22: Autoimmune Disease Diagnostics Market in Asia-Pacific by Country (2020-2028)
• Table 23: Autoimmune Disease Diagnostics Market in China (2020-2028)
• Table 24: Autoimmune Disease Diagnostics Market in Japan (2020-2028)
• Table 25: Autoimmune Disease Diagnostics Market in India (2020-2028)
• Table 26: Autoimmune Disease Diagnostics Market in Australia (2020-2028)
• Table 27: Autoimmune Disease Diagnostics Market in South Korea (2020-2028)
• Table 28: Autoimmune Disease Diagnostics Market in Rest of Asia-Pacific (2020-2028)
• Table 29: Autoimmune Disease Diagnostics Market in the Rest of the World (2020-2028)
• Table 30: Autoimmune Disease Diagnostics Market in RoW by Region (2020-2028)
• Table 31: Autoimmune Disease Diagnostics Market in the Middle East (2020-2028)
• Table 32: Autoimmune Disease Diagnostics Market in Africa (2020-2028)
• Table 33: Autoimmune Disease Diagnostics Market in South America (2020-2028)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Autoimmune Disease Diagnostics Market in Global (2020-2028)
• Figure 3: Autoimmune Disease Diagnostics Market in Global by Product (2020-2028)
• Figure 4: Autoimmune Disease Diagnostics Market in Global by Diseases Type (2020-2028)
• Figure 5: Autoimmune Disease Diagnostics Market in Global by Test (2020-2028)
• Figure 6: Autoimmune Disease Diagnostics Market in Global by End-user (2020-2028)
• Figure 7: Autoimmune Disease Diagnostics Market in Global by Geography (2020-2028)
• Figure 8: Autoimmune Disease Diagnostics Market in North America (2020-2028)
• Figure 9: Autoimmune Disease Diagnostics Market in North America by Country (2020-2028)
• Figure 10: Autoimmune Disease Diagnostics Market in the United States (2020-2028)
• Figure 11: Autoimmune Disease Diagnostics Market in Canada (2020-2028)
• Figure 12: Autoimmune Disease Diagnostics Market in Mexico (2020-2028)
• Figure 13: Autoimmune Disease Diagnostics Market in Europe (2020-2028)
• Figure 14: Autoimmune Disease Diagnostics Market in Europe by Country (2020-2028)
• Figure 15: Autoimmune Disease Diagnostics Market in France (2020-2028)
• Figure 16: Autoimmune Disease Diagnostics Market in Germany (2020-2028)
• Figure 17: Autoimmune Disease Diagnostics Market in the United Kingdom (2020-2028)
• Figure 18: Autoimmune Disease Diagnostics Market in Italy (2020-2028)
• Figure 19: Autoimmune Disease Diagnostics Market in Spain (2020-2028)
• Figure 20: Autoimmune Disease Diagnostics Market in the Rest of Europe (2020-2028)
• Figure 21: Autoimmune Disease Diagnostics Market in Asia-Pacific (2020-2028)
• Figure 22: Autoimmune Disease Diagnostics Market in Asia-Pacific by Country (2020-2028)
• Figure 23: Autoimmune Disease Diagnostics Market in China (2020-2028)
• Figure 24: Autoimmune Disease Diagnostics Market in Japan (2020-2028)
• Figure 25: Autoimmune Disease Diagnostics Market in India (2020-2028)
• Figure 26: Autoimmune Disease Diagnostics Market in Australia (2020-2028)
• Figure 27: Autoimmune Disease Diagnostics Market in South Korea (2020-2028)
• Figure 28: Autoimmune Disease Diagnostics Market in Rest of Asia-Pacific (2020-2028)
• Figure 29: Autoimmune Disease Diagnostics Market in the Rest of the World (2020-2028)
• Figure 30: Autoimmune Disease Diagnostics Market in RoW by Region (2020-2028)
• Figure 31: Autoimmune Disease Diagnostics Market in the Middle East (2020-2028)
• Figure 32: Autoimmune Disease Diagnostics Market in Africa (2020-2028)
• Figure 33: Autoimmune Disease Diagnostics Market in South America (2020-2028)
• Figure 34: Market Drivers
• Figure 35: Market Barriers
• Figure 36: Marker Opportunities
• Figure 37: PORTER'S Five Force Analysis

Autoimmune Disease Diagnostics Market By Product (Reagents & Kits And Instruments), Disease Type (Localized Autoimmune Disease, And Systemic Autoimmune Disease), Test (Antinuclear Antibody Test, Autoantibody Test, Complete Blood Count, Comprehensive Metabolic Panel, C-Reaction Protein, Erythrocyte Sedimentation Rate, And Urinalysis), By End-User (Hospitals & Clinics, Diagnostics Centers, And Others) and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of key diseases such as autoimmune disorders such as rheumatoid arthritis, diabetes, and multiple sclerosis.

The global Autoimmune Disease Diagnostics Market is estimated to grow at a CAGR of 5.53% during the forecast period from 2023 to 2028 to reach USD 6.41 billion by 2028. The demand for diagnosis of autoimmune diseases is primarily being boosted by the increasing number of cases of autoimmune disorders such as Rheumatoid Arthritis, Type I Diabetes, and Addison's Disease among others. Additionally, the rising awareness among people regarding early disease diagnosis and the rising technological advancement in the healthcare domain, are also contributing to the growth of the Autoimmune Diagnostics Market during the forecast period from 2023-2028.

Autoimmune Disease Diagnostics Market Dynamics:

As per the data published by Multiple Sclerosis International Federation in 2020, the number of people suffering from multiple sclerosis has increased from 2.3 million in 2013 to 2.8 billion in 2020, globally. Furthermore, according to statistics provided by the World Health Organization (WHO) in the year 2023, around 18 million individuals worldwide suffered from rheumatoid arthritis in 2019. According to the same source, around 70% of persons suffering from rheumatoid arthritis in 2019 were women, with 55% being over the age of 55. Thus the rising prevalence of autoimmune disorders will create a need for diagnosis of autoimmune disorders, thus resulting in the positive growth of the Autoimmune Disease Diagnostic Market.

Another driver for the Autoimmune Disease Diagnostics market is growing public awareness about early disease detection. For example, the Autoimmune Association recognizes Autoimmune Disease Awareness Month every March. The primary goal of the awareness campaign is to raise public knowledge and comprehension of autoimmune illnesses. Thus, increased disease awareness causes a requirement for early diagnosis of the ailments, which plays a critical role in driving the Autoimmune Disease Diagnostics Market.

However, the high cost of diagnosing autoimmune illnesses, as well as the long turnaround time and the requirement of many tests, are some of the key constraints that may limit the growth of the autoimmune disease diagnostic market.

Autoimmune Disease Diagnostics Market Segment Analysis:

Autoimmune Disease Diagnostics Market by Product (Reagents & Kits and Instruments), Disease type (Localized Autoimmune Disease and Systemic Autoimmune Disease), Test (Antinuclear Antibody Test, Autoantibody Test, Complete Blood Count, Comprehensive Metabolic Panel, C-reaction Protein, Erythrocyte Sedimentation Rate, and Urinalysis), End-users (Hospitals & Clinics, Diagnostic Centers, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

The Reagents & Kits category is estimated to account for a considerable revenue share in the Autoimmune Disease Diagnostics Market in 2022. This might be linked to the increased demand and consumption of kits and reagents, as well as the increasing number of tests done, as a result of the growing incidence of autoimmune illnesses worldwide. Furthermore, many benefits given by kits, including high sensitivity and excellent specificity, are some of the reasons contributing to the segment's rise.

Furthermore, the kits and reagents are required for every test, making them an essential element of the testing procedure during the illness diagnostic process.

Furthermore, as the demand for this segment grows, novel products are being approved by various regulatory agencies. For example, in June 2021, Inova Diagnostics, a global pioneer in the development of in-vitro diagnostic reagents and systems for autoimmune illnesses, gained FDA 510(k) clearance in the United States for its Aptiva® Celiac Disease IgA test.

As a result of the aforementioned factors, the reagents and kits segment is expected to grow significantly during the forecast period, consequently driving the expansion of the overall Autoimmune Disease Diagnostics Market.

North America is expected to dominate the overall Autoimmune Disease Diagnostics Market:

North America is expected to account for the highest proportion of the Autoimmune Disease Diagnostics Market in 2022, out of all regions. This is due to the existence of a significant patient pool in the region suffering from autoimmune illness. Furthermore, increased consumer awareness of illness diagnosis, support from the government, and a highly viable market in terms of product development and launches are some of the factors driving the growth of the Autoimmune Disease Diagnostics Market in North America.

According to statistics given by the Centers for Disease Control and Prevention (CDC) in 2023, it was estimated that around 21.2% of people (53.2 million) in the United States were diagnosed with arthritis between 2019 and 2021.

Further, according to the data provided by Multiple Sclerosis Canada 2020, over 90,000 people live with Multiple Sclerosis in Canada every year on average, which accounts for 1 in every 400 individuals. Thus according to the above-mentioned facts, this indicates a huge need for early diagnosis for the detection of autoimmune disorders therefore leading to the growth of the Autoimmune Disease Diagnostics market in North America.

Thus, the factors mentioned above, are thereby responsible for driving the North America Autoimmune Disease Diagnostics Market forward during the forecast period.

Autoimmune Disease Diagnostics Market Key Players:

Some of the key market players operating in the Autoimmune Disease Diagnostics Market include: Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, Werfen, Bio-Rad Laboratories, Exagen Inc., Grifols, S.A, Medical & Biological Laboratories Co. Ltd, RSR Limited, DiaSorin S.p.A, Laboratory Corporation of America Holdings, Abcam plc, EUROIMMUN Medizinische Labordiagnostika AG, Quest Diagnostics, Hemagen Diagnostics, Inc., AESKU Diagnostics GmbH & Co. KG, Trinity Biotech and Biomerieux SA.

Recent Developmental Activities in the Autoimmune Disease Diagnostics Market:

• In October 2022, Sebia, a global specialty diagnostic company engaged in providing innovative solutions for screening and diagnosis of oncological, metabolic, genetic, and autoimmune disorders, acquired ZEUS Scientific.
• In May 2022, Thermofisher Scientific launched The new Phadia 2500+ series in the US, for the diagnosis of autoimmune disorders.
• In November 2020, Exagen and GSK partnered for 4th time consecutively, to create awareness of challenges facing lupus diagnosis and management.

Key Takeaways from the Autoimmune Disease Diagnostics Market Report Study:

• Market size analysis for current Autoimmune Disease Diagnostics Market size (2022), and market forecast for 5 years (2023-2028)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Autoimmune Disease Diagnostics market.
• Various opportunities available for the other competitor in the Autoimmune Disease Diagnostics Market space.
• What are the top-performing segments in 2022? How these segments will perform in 2028?
• Which are the top-performing regions and countries in the current Autoimmune Disease Diagnostics Market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Autoimmune Disease Diagnostics Market growth in the coming future?

Target Audience who can be benefited from this Autoimmune Disease Diagnostics Market Report Study:

• Autoimmune Disease Diagnostics product providers
• Research organizations and consulting companies
• Autoimmune Disease Diagnostics-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Autoimmune Disease Diagnostics
• Various End-users who want to know more about the Autoimmune Disease Diagnostics Market and the latest technological developments in the Autoimmune Disease Diagnostics Market.

Frequently Asked Questions for the Autoimmune Disease Diagnosis Market:

1. What is meant by Autoimmune Disorder?

• Autoimmune Disorder is a condition in which the immune system mistakenly targets and attacks healthy cells, tissues, and organs in the body. This immune dysfunction can lead to inflammation and damage to the body tissues.

2. What is the market for global Autoimmune Disease Diagnostics?

• The global Autoimmune Disease Diagnostics Market is estimated to grow at a CAGR of 5.53% during the forecast period from 2023 to 2028 to reach USD 6.41 billion by 2028.

3. What are the drivers for the global Autoimmune Disease Diagnostics market?

• The Autoimmune Disease Diagnostics Market is slated to witness prosperity owing to factors such as the growing prevalence of autoimmune disorders such as Rheumatoid Arthritis, Type I Diabetes, and Multiple Sclerosis, among others. Additionally, growing awareness regarding early disease diagnosis and increasing research activities in the domain of autoimmune disease, are expected to result in appreciable revenue growth in the Autoimmune Disease Diagnostics Market during the forecast period (2023-2028).

4. Who are the key players operating in the global autoimmune disease diagnostics market?

• Some of the key market players operating in the Autoimmune Disease Diagnostics Market include Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, Werfen, Bio-Rad Laboratories, Exagen Inc., Grifols, S.A, Medical & Biological Laboratories Co. Ltd., RSR Limited, DiaSorin S.p.A, Laboratory Corporation of America Holdings, Abcam plc, EUROIMMUN Medizinische Labordiagnostika AG, Quest Diagnostics, Hemagen Diagnostics, Inc., AESKU Diagnostics GmbH & Co. KG, Trinity Biotech and Biomerieux SA.

5. Which region has the highest share in the global Autoimmune Disease Diagnostics market?

• North America is expected to dominate the overall Autoimmune Disease Diagnostics Market during the forecast period, 2023 to 2028. This can be attributed to the presence of a large patient pool suffering from autoimmune disorders. Additionally, high consumer awareness regarding new market launches, government support, a highly potent market in terms of product development and launches, and the local presence of key market players are some of the factors influencing the positive growth of the market in the region during the forecast period.

Table of Contents

1. Autoimmune Disease Diagnostic Market Report Introduction

2. Autoimmune Disease Diagnostics Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Autoimmune Disease Diagnostics Market Key Factors Analysis

• 4.1. Autoimmune Disease Diagnostics Market Drivers
  • 4.1.1. Increasing prevalence of Autoimmune Disorders around the globe
  • 4.1.2. Growing awareness among people regarding early diseases diagnosis
  • 4.1.3. Increasing research in the domain of the Autoimmune Disorders
• 4.2. Autoimmune Disease Diagnostics Market Restraints and Challenges
  • 4.2.1. High Cost associated with the diagnostic tests
  • 4.2.2. Slow turnaround time and requirement of multiple diagnostics test
• 4.3. Autoimmune Disease Diagnostics Market Opportunities
  • 4.3.1. Development of novel methods for detecting Autoimmune disorders
  • 4.3.2. Continuous research and development in the Pharma and Biotech Sector

5. Autoimmune Disease Diagnostics Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Autoimmune Disease Diagnostics Market Layout

• 6.1. By Products
  • 6.1.1. Reagents & Kits
  • 6.1.2. Instruments
• 6.2. By Diseases Type
  • 6.2.1. Localized Autoimmune Disease
  • 6.2.2. Systemic Autoimmune Disease
• 6.3. By Test
  • 6.3.1. Antinuclear Antibody Test
  • 6.3.2. Autoantibody Test
  • 6.3.3. Comprehensive Metabolic Panel
  • 6.3.4. C-reactive Protein
  • 6.3.5. Others
• 6.4. By End-user
  • 6.4.1. Hospitals and Clinics
  • 6.4.2. Diagnostic Centers
  • 6.4.3. Others
• 6.5. By Geography
  • 6.5.1. North America
    • 6.5.1.1. United States Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.1.2. Canada Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.1.3. Mexico Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
  • 6.5.2. Europe
    • 6.5.2.1. France Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.2.2. Germany Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.2.3. United Kingdom Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.2.4. Italy Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.2.5. Spain Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.2.6. Rest of Europe Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
  • 6.5.3. Asia-Pacific
    • 6.5.3.1. China Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.3.2. Japan Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.3.3. India Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.3.4. Australia Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.3.5. South Korea Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.3.6. Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
  • 6.5.4. Rest of the World (RoW)
    • 6.5.4.1. Middle East Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.4.2. Africa Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)
    • 6.5.4.3. South America Autoimmune Disease Diagnostics Market Size in USD million (2020-2028)

7. Autoimmune Diagnostics Market Company and Product Profiles

• 7.1. Bio-Rad Laboratories
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Thermo Fisher Scientific
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. F. Hoffmann-La Roche Ltd.
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Abbott Laboratories
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Grifols, S.A
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Beckman Coulter, Inc.
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Siemens Healthineers
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Exagen Inc.
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Medical & Biological Laboratories Co. Ltd.
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. RSR Limited
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. DiaSorin S.p.A
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Werfen
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. EUROIMMUN Medizinische Labordiagnostika AG
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. Laboratory Corporation of America Holdings
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Abcam plc
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy
• 7.16. Quest Diagnostics
  • 7.16.1. Company Overview
  • 7.16.2. Company Snapshot
  • 7.16.3. Financial Overview
  • 7.16.4. Product Listing
  • 7.16.5. Entropy
• 7.17. Hemagen Diagnostics, Inc
  • 7.17.1. Company Overview
  • 7.17.2. Company Snapshot
  • 7.17.3. Financial Overview
  • 7.17.4. Product Listing
  • 7.17.5. Entropy
• 7.18. AESKU Diagnostics GmbH & Co. KG
  • 7.18.1. Company Overview
  • 7.18.2. Company Snapshot
  • 7.18.3. Financial Overview
  • 7.18.4. Product Listing
  • 7.18.5. Entropy
• 7.19. Trinity Biotech
  • 7.19.1. Company Overview
  • 7.19.2. Company Snapshot
  • 7.19.3. Financial Overview
  • 7.19.4. Product Listing
  • 7.19.5. Entropy
• 7.20. Biomerieux SA.
  • 7.20.1. Company Overview
  • 7.20.2. Company Snapshot
  • 7.20.3. Financial Overview
  • 7.20.4. Product Listing
  • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us